Business
Result of Meeting
Result of Meeting.
About this update from Fortis Frontier Plc
[{"type":"text","content":"\n \nRNS Number : 1085X Concepta PLC 25 April 2019 \n\n \n25 April 2019\nConcepta plc\nResult of Meeting\nAt the general meeting of the Company held earlier today, all the resolutions were passed by shareholders. The 76,750,000 new ordinary shares of 2.5 pence per share (\"Ordinary Shares\") issued in the placing at 3 pence per share, as announced on 8 April 2019, are expected to be admitted to trading at 8.00 a.m. on 26 April 2019. \nThe Group will issue its 2018 Financial Year preliminary results announcement on 14th May 2019.\nEnquiries\nCompany: www.conceptaplc.com, Product: www.mylotus.com\nMatthew Walls, Chairman\nTel: +44 (0) 1234 866601\nSPARK Advisory Partners Limited (Nominated Adviser)\nNeil Baldwin\nTel: +44 (0)20 368 3550\nNovum Securities\nColin Rowbury\n+44 (0) 20 7399 9400\nAbout Concepta Plc:\nConcepta Plc is an AIM-quoted pioneering UK healthcare company that has developed a proprietary product, myLotus®, targeted at the personalised mobile health market with a primary focus on hormone testing and increasing a woman's chances of naturally getting pregnant and to provide insight to unexplained infertility.\nmyLotus® is currently the only consumer product which allows both quantitative and qualitative home (self-test) test measurement of a woman's personal luteinizing hormone (LH) during ovulation and human chorionic gonadotropin (hCG) hormone level during pregnancy, facilitating higher conception\nrates and early diagnosis of fertility issues. The proposition of myLotus® is to empower women to better understand their hormone levels and menstrual cycle and help women conceive naturally by identifying their window of fertility and optimal time for conception.\nThe Company has received CE-mark certification for myLotus® and has launched its first product in the UK. The Company is preparing plans to roll-out across the core EU countries in 2019.\nmyLotus® is expected to be beneficial to users who have been unable to conceive after 6 months of trying. This highly motivated target group of women won't typically be offered medical intervention until after 12 months of unsuccessfully trying to conceive, with IVF not usually offered until after two years of trying to conceive. Research indicates couples start to take positive action ahead of this time typically with little medical support to hel...